578 related articles for article (PubMed ID: 26722033)
1. Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays.
Elgqvist J; Timmermand OV; Larsson E; Strand SE
Anticancer Res; 2016 Jan; 36(1):103-9. PubMed ID: 26722033
[TBL] [Abstract][Full Text] [Related]
2. Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.
Nilsson J; Bauden MP; Nilsson JM; Strand SE; Elgqvist J
Cancer Biother Radiopharm; 2015 Nov; 30(9):386-94. PubMed ID: 26560194
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
Nayak TK; Norenberg JP; Anderson TL; Prossnitz ER; Stabin MG; Atcher RW
Nucl Med Biol; 2007 Feb; 34(2):185-93. PubMed ID: 17307126
[TBL] [Abstract][Full Text] [Related]
4. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
[TBL] [Abstract][Full Text] [Related]
5. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.
Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
Radiat Res; 2014 Jan; 181(1):90-8. PubMed ID: 24502376
[TBL] [Abstract][Full Text] [Related]
6. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the progression of cells through the cell cycle after exposure to alpha particles or gamma rays.
Gadbois DM; Crissman HA; Nastasi A; Habbersett R; Wang SK; Chen D; Lehnert BE
Radiat Res; 1996 Oct; 146(4):414-24. PubMed ID: 8927713
[TBL] [Abstract][Full Text] [Related]
8. Preclinical efficacy of hK2 targeted [
Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand SE
Theranostics; 2019; 9(8):2129-2142. PubMed ID: 31149033
[TBL] [Abstract][Full Text] [Related]
9. Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
Wild D; Frischknecht M; Zhang H; Morgenstern A; Bruchertseifer F; Boisclair J; Provencher-Bolliger A; Reubi JC; Maecke HR
Cancer Res; 2011 Feb; 71(3):1009-18. PubMed ID: 21245097
[TBL] [Abstract][Full Text] [Related]
10. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
[TBL] [Abstract][Full Text] [Related]
12. Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assay.
Palm S; Bäck T; Claesson I; Delle U; Hultborn R; Jacobsson L; Köpf I; Lindegren S
Anticancer Res; 1998; 18(3A):1671-6. PubMed ID: 9673388
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
[TBL] [Abstract][Full Text] [Related]
14. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
[TBL] [Abstract][Full Text] [Related]
15. Biochemical alterations in human cells irradiated with alpha particles delivered by macro- or microbeams.
Gault N; Rigaud O; Poncy JL; Lefaix JL
Radiat Res; 2007 May; 167(5):551-62. PubMed ID: 17474787
[TBL] [Abstract][Full Text] [Related]
16. Response of chronic hypoxic cells to low dose-rate irradiation.
Pettersen EO; Bjørhovde I; Søvik A; Edin NF; Zachar V; Hole EO; Sandvik JA; Ebbesen P
Int J Radiat Biol; 2007 May; 83(5):331-45. PubMed ID: 17457758
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitivity of colorectal cancer to
Lee BQ; Abbott EM; Able S; Thompson JM; Hill MA; Kartsonaki C; Vallis KA; Falzone N
Phys Med Biol; 2019 Jul; 64(13):135018. PubMed ID: 31117062
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular diseases incidence and mortality in an extended Mayak Worker Cohort 1948-1982.
Azizova TV; Haylock RG; Moseeva MB; Bannikova MV; Grigoryeva ES
Radiat Res; 2014 Nov; 182(5):529-44. PubMed ID: 25361397
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.
Carlson DJ; Stewart RD; Li XA; Jennings K; Wang JZ; Guerrero M
Phys Med Biol; 2004 Oct; 49(19):4477-91. PubMed ID: 15552412
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model.
Saga R; Matsuya Y; Takahashi R; Hasegawa K; Date H; Hosokawa Y
J Radiat Res; 2019 May; 60(3):298-307. PubMed ID: 31034058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
